Pfizer CEO Albert Bourla on Covid-19 vaccine manufacturing outlook
Pfizer CEO Albert Bourla told CNBC’s “Squawk Box” Tuesday that the company plans to increase coronavirus vaccine production this year,
Read morePfizer CEO Albert Bourla told CNBC’s “Squawk Box” Tuesday that the company plans to increase coronavirus vaccine production this year,
Read moreA coronavirus vaccine developed by Pfizer and BioNTech appears to be effective against a key mutation in the more infectious
Read moreTwo health workers in New York volunteer to be the first people vaccinated in the state. For access to live
Read moreCountries around the world have begun to approve the most anticipated vaccine of the 21st century — but getting it
Read moreThe U.K. on Wednesday authorized the Pfizer-BioNTech vaccine for emergency use, marking another step in the global battle against the
Read moreDr. Lloyd Minor, dean of Stanford Medicine, joins “Squawk on the Street” to discuss the push for a coronavirus vaccine.
Read moreDr. Francis Collins, who is the National Institutes of Health director, joins Shepard Smith to talk about his outlook on
Read moreDr. Scott Gottlieb, former FDA commissioner and Pfizer board member, joins “Closing Bell” to discuss comments from Pfizer that a
Read moreCNBC’s “Squawk Alley” discusses how vaccine treatment and timelines with Matthew Harrison of Morgan Stanley.
Read moreCNBC’s Meg Tirrell joins “Squawk on the Street” to break down final guidelines on who will get the coronavirus vaccine
Read more